TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Common Stock, Shares, Issued 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Teva Pharmaceutical Industries Ltd quarterly Common Stock, Shares, Issued history and growth rate from 2010 to 2024.
  • Teva Pharmaceutical Industries Ltd Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 1.24 B shares, a 0.98% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 1.24 B +12 M +0.98% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 1.23 B +10 M +0.82% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 1.23 B +11 M +0.91% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.23 B +1.23 B +100904505% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 1.23 B +10 M +0.82% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 1.22 B +8 M +0.66% Dec 31, 2022 10-K 2024-02-12
Q3 2022 1.22 B +7 M +0.58% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 1.22 K* -1.21 B -100% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 1.22 B +8 M +0.66% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 1.21 B +7 M +0.58% Dec 31, 2021 10-K 2023-02-10
Q3 2021 1.21 B +7 M +0.58% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 1.21 B +7 M +0.58% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 1.21 B +7 M +0.58% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 1.2 B +4 M +0.33% Dec 31, 2020 10-K 2022-02-09
Q3 2020 1.2 B +4 M +0.33% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 1.2 B +4 M +0.33% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 1.2 B +3 M +0.25% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 1.2 B +2 M +0.17% Dec 31, 2019 10-K 2021-02-10
Q3 2019 1.2 B +73 M +6.49% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 1.2 B +74 M +6.58% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 1.2 B +74 M +6.58% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 1.2 B +72 M +6.41% Dec 31, 2018 10-K 2020-02-21
Q3 2018 1.13 B Sep 30, 2018 10-Q 2018-11-01
Q2 2018 1.12 B Jun 30, 2018 10-Q 2018-08-02
Q1 2018 1.12 B Mar 31, 2018 10-Q 2018-05-03
Q4 2017 1.12 B +1 M +0.09% Dec 31, 2017 10-K 2019-02-19
Q4 2016 1.12 B +107 M +10.5% Dec 31, 2016 20-F 2017-02-15
Q3 2016 1.12 B +162 M +16.9% Sep 30, 2016 6-K 2016-11-15
Q2 2016 1.02 B +62 M +6.46% Jun 30, 2016 6-K 2016-08-04
Q1 2016 1.02 B +63 M +6.57% Mar 31, 2016 6-K 2016-05-09
Q4 2015 1.02 B +59 M +6.17% Dec 31, 2015 20-F 2017-02-15
Q3 2015 961 M +9 M +0.95% Sep 30, 2015 6-K 2015-10-29
Q2 2015 960 M +9 M +0.95% Jun 30, 2015 6-K 2015-07-30
Q1 2015 959 M +10 M +1.05% Mar 31, 2015 6-K 2015-04-30
Q4 2014 957 M +10 M +1.06% Dec 31, 2014 20-F 2016-02-11
Q3 2014 952 M +8 M +0.85% Sep 30, 2014 6-K 2014-10-30
Q2 2014 951 M +7 M +0.74% Jun 30, 2014 6-K 2014-07-31
Q1 2014 949 M +5 M +0.53% Mar 31, 2014 6-K 2014-05-02
Q4 2013 947 M +3 M +0.32% Dec 31, 2013 20-F 2015-02-09
Q3 2013 944 M +1 M +0.11% Sep 30, 2013 6-K 2013-10-31
Q2 2013 944 M +1 M +0.11% Jun 30, 2013 6-K 2013-08-01
Q1 2013 944 M +2 M +0.21% Mar 31, 2013 6-K 2013-05-02
Q4 2012 944 M +2 M +0.21% Dec 31, 2012 20-F 2014-02-10
Q3 2012 943 M +2 M +0.21% Sep 30, 2012 6-K 2012-11-01
Q2 2012 943 M +3 M +0.32% Jun 30, 2012 6-K 2012-08-02
Q1 2012 942 M +2 M +0.21% Mar 31, 2012 6-K 2012-05-09
Q4 2011 942 M +5 M +0.53% Dec 31, 2011 20-F 2013-02-12
Q3 2011 941 M +5 M +0.53% Sep 30, 2011 6-K 2011-11-02
Q2 2011 940 M +5 M +0.54% Jun 30, 2011 6-K 2011-07-28
Q1 2011 940 M +9 M +0.97% Mar 31, 2011 6-K 2011-05-11
Q4 2010 937 M Dec 31, 2010 20-F 2012-02-17
Q3 2010 936 M Sep 30, 2010 6-K 2010-11-02
Q2 2010 935 M Jun 30, 2010 6-K 2010-07-27
Q1 2010 931 M Mar 31, 2010 6-K 2010-05-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.